Combination therapy for management of pemphigus patients with unexpected therapeutic response to rituximab: A report of five cases.

Aryanian, Zeinab; Riyaz, Insha Zainab; Balighi, Kamran; Ahmadzade, Ali; Mahmoudi, Hamid Reza; Azizpour, Arghavan; Hatami, Parvaneh

Aryanian, Zeinab; Riyaz, Insha Zainab; Balighi, Kamran; Ahmadzade, Ali; Mahmoudi, Hamid Reza; Azizpour, Arghavan; Hatami, Parvaneh.

Afiliación

Aryanian Z; Autoimmune Bullous Diseases Research Center Razi Hospital Tehran University of Medical Sciences Tehran Iran.
Riyaz IZ; Department of Dermatology Babol University of Medical Sciences Babol Iran.
Balighi K; Department of Dermatology School of Medicine Razi Hospital Tehran University of Medical Sciences Tehran Iran.
Ahmadzade A; Autoimmune Bullous Diseases Research Center Razi Hospital Tehran University of Medical Sciences Tehran Iran.
Mahmoudi HR; Autoimmune Bullous Diseases Research Center Razi Hospital Tehran University of Medical Sciences Tehran Iran.
Azizpour A; Department of Dermatology School of Medicine Razi Hospital Tehran University of Medical Sciences Tehran Iran.
Hatami P; Autoimmune Bullous Diseases Research Center Razi Hospital Tehran University of Medical Sciences Tehran Iran.

Clin Case Rep ; 11(11): e8208, 2023 Nov.

Article en En | MEDLINE | ID: mdl-38028089

Palabras clave

dapsone; methotrexate; mycophenolic acid; pemphigus; pemphigus worsening; rituximab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Case Rep Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google